These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30382361)
1. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation. Hao W; Li M; Zhang C; Zhang Y; Xue Y Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361 [TBL] [Abstract][Full Text] [Related]
2. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers. Hao W; Li M; Zhang Y; Zhang C; Wang P Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557 [TBL] [Abstract][Full Text] [Related]
3. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD. Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804 [TBL] [Abstract][Full Text] [Related]
4. Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD. Kim C; Ko Y; Kim SH; Yoo HJ; Lee JS; Rhee CK; Lee JH; Lee JH; Kim TH; Lim SY; Yoo KH; Seo JB; Oh YM; Lee SD; Park YB Respirology; 2018 Feb; 23(2):176-181. PubMed ID: 28905464 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease. Hao W; Li M; Zhang C; Zhang Y; Du W Cytokine; 2020 Feb; 126():154881. PubMed ID: 31629111 [TBL] [Abstract][Full Text] [Related]
6. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD. Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734 [TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity. Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452 [TBL] [Abstract][Full Text] [Related]
9. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk. Langholm LL; Rønnow SR; Sand JMB; Leeming DJ; Tal-Singer R; Miller BE; Vestbo J; Karsdal MA; Manon-Jensen T Int J Chron Obstruct Pulmon Dis; 2020; 15():543-552. PubMed ID: 32210548 [TBL] [Abstract][Full Text] [Related]
10. Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease. Sugiyama Y; Asai K; Yamada K; Kureya Y; Ijiri N; Watanabe T; Kanazawa H; Hirata K Int J Chron Obstruct Pulmon Dis; 2017; 12():765-772. PubMed ID: 28424548 [TBL] [Abstract][Full Text] [Related]
11. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Wei X; Ma Z; Yu N; Ren J; Jin C; Mi J; Shi M; Tian L; Gao Y; Guo Y Int J Chron Obstruct Pulmon Dis; 2018; 13():121-129. PubMed ID: 29343951 [TBL] [Abstract][Full Text] [Related]
12. Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. Occhipinti M; Paoletti M; Bigazzi F; Camiciottoli G; Inchingolo R; Larici AR; Pistolesi M Radiology; 2018 May; 287(2):683-692. PubMed ID: 29361243 [TBL] [Abstract][Full Text] [Related]
13. Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients. Lim JU; Kim EK; Lim SY; Lee JH; Lee JS; Lee SD; Oh YM; Rhee CK; Int J Chron Obstruct Pulmon Dis; 2019; 14():3035-3042. PubMed ID: 31920300 [TBL] [Abstract][Full Text] [Related]
14. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome. Xie M; Wang W; Dou S; Cui L; Xiao W Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for FEV Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155 [TBL] [Abstract][Full Text] [Related]
16. Blood eosinophil count as a prognostic biomarker in COPD. Oh YM; Lee KS; Hong Y; Hwang SC; Kim JY; Kim DK; Yoo KH; Lee JH; Kim TH; Lim SY; Rhee CK; Yoon HK; Lee SY; Park YB; Jung JH; Kim WJ; Lee SD; Park JH Int J Chron Obstruct Pulmon Dis; 2018; 13():3589-3596. PubMed ID: 30464441 [TBL] [Abstract][Full Text] [Related]
17. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease. Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714 [TBL] [Abstract][Full Text] [Related]
18. Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD. Kurashima K; Takaku Y; Hoshi T; Kanauchi T; Nakamoto K; Takayanagi N; Yanagisawa T; Sugita Y; Kawabata Y Int J Chron Obstruct Pulmon Dis; 2015; 10():1027-33. PubMed ID: 26082626 [TBL] [Abstract][Full Text] [Related]